StemRIM (4599.T)

JPY 317.0

(-0.63%)

Net Debt Summary of StemRIM

  • StemRIM's latest annual net debt in 2024 was -8.41 Billion JPY , up 17.69% from previous year.
  • StemRIM's latest quarterly net debt in 2024 Q3 was -8.73 Billion JPY , up 4.85% from previous quarter.
  • StemRIM reported annual net debt of -10.21 Billion JPY in 2023, down -15.1% from previous year.
  • StemRIM reported annual net debt of -8.87 Billion JPY in 2022, up 12.68% from previous year.
  • StemRIM reported quarterly net debt of -9.78 Billion JPY for 2024 Q1, up 4.21% from previous quarter.
  • StemRIM reported quarterly net debt of -8.41 Billion JPY for 2024 Q4, up 3.76% from previous quarter.

Annual Net Debt Chart of StemRIM (2024 - 2017)

Historical Annual Net Debt of StemRIM (2024 - 2017)

Year Net Debt Net Debt Growth
2024 -8.41 Billion JPY 17.69%
2023 -10.21 Billion JPY -15.1%
2022 -8.87 Billion JPY 12.68%
2021 -10.16 Billion JPY 4.69%
2020 -10.66 Billion JPY -329.4%
2019 -2.48 Billion JPY -34.74%
2018 -1.84 Billion JPY -103.84%
2017 -904.31 Million JPY 0.0%

Peer Net Debt Comparison of StemRIM

Name Net Debt Net Debt Difference
KOHJIN BIO CO LTD 742.75 Million JPY 1232.265%
PRISM BioLab Co.,LTD -1.13 Billion JPY -641.66%
GNI Group Ltd. -17.93 Billion JPY 53.105%
Linical Co., Ltd. -4.46 Billion JPY -88.426%
Trans Genic Inc. -221.16 Million JPY -3702.522%
MEDINET Co., Ltd. -4.39 Billion JPY -91.396%
Soiken Holdings Inc. -4.79 Billion JPY -75.573%
Cytori Cell Research Institute, Inc. 1.43 Billion JPY 686.661%
AnGes, Inc. -3.79 Billion JPY -121.447%
OncoTherapy Science, Inc. -420.8 Million JPY -1898.541%
Nxera Pharma Co., Ltd. 24.9 Billion JPY 133.764%
Immuno-Biological Laboratories Co., Ltd. -498.15 Million JPY -1588.233%
NanoCarrier Co., Ltd. -466.34 Million JPY -1703.378%
Carna Biosciences, Inc. -2.7 Billion JPY -210.776%
CanBas Co., Ltd. -1.88 Billion JPY -345.398%
D. Western Therapeutics Institute, Inc. -982.14 Million JPY -756.292%
RaQualia Pharma Inc. -3.39 Billion JPY -147.57%
Chiome Bioscience Inc. -1.03 Billion JPY -712.911%
Kidswell Bio Corporation 343.58 Million JPY 2547.692%
PeptiDream Inc. 3.29 Billion JPY 355.468%
Oncolys BioPharma Inc. -972.59 Million JPY -764.699%
Ribomic Inc. -2.09 Billion JPY -300.525%
SanBio Company Limited -3.78 Billion JPY -121.916%
Healios K.K. -2.19 Billion JPY -284.018%
BrightPath Biotherapeutics Co., Ltd. -944.85 Million JPY -790.079%
Kubota Pharmaceutical Holdings Co., Ltd. -2.62 Billion JPY -220.485%
Delta-Fly Pharma, Inc. -1.41 Billion JPY -493.481%
CellSource Co., Ltd. -4.68 Billion JPY -79.567%
FunPep Company Limited -1.79 Billion JPY -368.947%
Kringle Pharma, Inc. -2.13 Billion JPY -293.636%
Stella Pharma Corporation -1.11 Billion JPY -651.293%
TMS Co., Ltd. -3.44 Billion JPY -144.006%
Noile-Immune Biotech Inc. -5.55 Billion JPY -51.376%
Cuorips Inc. -5.56 Billion JPY -51.232%
K Pharma,Inc. -3.26 Billion JPY -157.469%
Takara Bio Inc. -32.2 Billion JPY 73.884%
ReproCELL Incorporated -2.93 Billion JPY -186.146%
PhoenixBio Co., Ltd. -660.96 Million JPY -1172.392%
StemCell Institute Inc. -2.83 Billion JPY -196.465%
Japan Tissue Engineering Co., Ltd. -2.06 Billion JPY -306.999%
CellSeed Inc. -2.01 Billion JPY -317.983%